Shuai Fu
- Orthopedics and Sports Medicine top 10%
-
- Renal cell carcinoma treatment 8
- Lung Cancer Treatments and Mutations 4
-
- Pancreatic and Hepatic Oncology Research 4
- Cancer Immunotherapy and Biomarkers 4
- Lung Cancer Research Studies 4
-
- Cancer Genomics and Diagnostics 4
-
- Renal and related cancers 5
-
- Bladder and Urothelial Cancer Treatments 4
Shuai Fu
44 papers receiving 469 citations
Peers
Comparison fields: 5 of 76
- Orthopedics and Sports Medicine 48
- Critical Care and Intensive Care Medicine 25
- Pulmonary and Respiratory Medicine 158
- Oncology 131
- Cancer Research 66
Countries citing papers authored by Shuai Fu
This map shows the geographic impact of Shuai Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuai Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuai Fu more than expected).
Fields of papers citing papers by Shuai Fu
This network shows the impact of papers produced by Shuai Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuai Fu. The network helps show where Shuai Fu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shuai Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 14 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 19 | |
| 7 | 2024 | 4 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 20 | |
| 10 | 2023 | 5 | |
| 11 | 2022 | 3 | |
| 12 | 2021 | 20 | |
| 13 | 2021 | 6 | |
| 14 | 2020 | 14 | |
| 15 | 2020 | 1 | |
| 16 | 2020 | 8 | |
| 17 | 2018 | 8 | |
| 18 | 2017 | 43 | |
| 19 | 2017 | 33 | |
| 20 | 2014 | 19 |
About Shuai Fu
Shuai Fu is a scholar working on Oncology, Equine and Cancer Research, having authored 52 papers that have together received 476 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (8 papers), Renal and related cancers (5 papers), Pancreatic and Hepatic Oncology Research (4 papers), Cancer Genomics and Diagnostics (4 papers), Lung Cancer Treatments and Mutations (4 papers), Bladder and Urothelial Cancer Treatments (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Lung Cancer Research Studies (4 papers). The work is most often cited by research in Orthopedics and Sports Medicine (48 citations), Critical Care and Intensive Care Medicine (25 citations) and Pulmonary and Respiratory Medicine (158 citations). Shuai Fu has collaborated with scholars based in China, United States and France. Frequent co-authors include Mingbo Zhang, Yutao Liu, Jie Tang, Billy Amzal, Ligang Cui, Hélène Karcher, Jie Meng, J. Lister, Nengwang Yu and Faqin Lv. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.